POSCO to sell entire stake in Nippon Steel, ending equity ties
POSCO Holdings Inc. has decided to sell its entire stake in Nippon Steel Corp., according to industry sources on Wednesday, marking the end of their...
Dongkuk to file anti-dumping petition vs Chinese color steel imports
Dongkuk Coated Metal Co. and SeAh Steel Corp. are set to file an anti-dumping complaint against Chinese rivals in March as the country plans to impo...
South Korea to levy 38% anti-dumping duties on Chinese steel products
South Korea plans to impose up to 38% provisional anti-dumping duties on Chinese hot-rolled steel plates starting next month, judging that those pro...
Korea to probe Chinese, Japanese steel imports over anti-dumping claims
South Korea is set to launch an anti-dumping investigation into hot-rolled steel imports from China and Japan, according to government and industry ...
South Korea’s steel imports from China at 7-year high
South Korea’s imports of steel products from China climbed to their highest level in seven years despite a decrease in its total steel imports...
Korean paper makers to file anti-dumping complaint vs Japanese rivals
South Korean corrugated cardboard sheet makers such as Asia Paper Manufacturing Co. have decided to file an anti-dumping complaint against Japanese ...
Hanmi Pharma to move up launch of anti-obesity drug
South Korea’s Hanmi Pharmaceutical Co. announced on Thursday the launch of its anti-obesity drug candidate efpeglenatide has been rescheduled ...
Czech anti-trust body puts signing of nuclear power deal on hold
The Czech anti-trust body put a temporary block on the conclusion of a contract with Korea Hydro & Nuclear Power Co. (KHNP) for the construction...
Celltrion's anti cancer drugs hold 90% market share in C.America
South Korea’s Celltrion Inc. said on Friday that its cancer treatments have captured a 90% market share in several Central American countries....
South Korea scraps anti-nuclear policy with approval of two nuclear plants
South Korea has approved the construction of two nuclear power plants, officially ending its anti-nuclear policy pursued by the previous Moon Jae-in...
Samhwa Paint launches anti-rust product Knok-Stop
South Korea's Samhwa Paint Industrial said on Wednesday that it has introduced a new water-based primer, Knok-Stop, designed to convert rust on meta...
S.Korea, China's technology leak, anti-dumping disputes surge
South Korean companies are getting tough on anti-dumping and patent infringement cases as they feel threatened by the intensifying price competition...
LG Energy Solution acquires anti-bribery certification
South Korea's LG Energy Solution Ltd. announced on Thursday that it achieved ISO 37001 certification, an international standard for anti-bribery man...
Lotte Chemical develops anti-thermal runaway material
Lotte Chemical Corp., South Korea’s second-largest petrochemicals company seeking to ramp up value-added advanced materials production, has de...
Coupang fined $102 mn for alleged search algorithm manipulation
Coupang Inc., South Korea’s largest e-commerce platform, was fined 140 billion won ($102 million) on Thursday for allegedly manipulating searc...
S.Korean anti-obesity drugmakers eye niche demand
The global weight management market has entered a new chapter following the arrival of blockbuster weight-loss medication Wegovy, and South Korean l...
Korean steelmakers mull anti-dumping suit vs Chinese, Japanese firms
Under growing pressure from increased imports of cheap Chinese and Japanese steel products, South Korean steelmakers are considering filing an anti-...
SK Biopharm, Dong-A ST sign licensing deal of Cenobamate
South Korea's SK Biopharmaceuticals Co. announced on Thursday that it has signed a contract with Dong-A ST to transfer the rights to commercialize t...
Hanwha wins S.Korean military anti-drone system deals
South Korean aerospace and defense maker Hanwha Systems Co. is set to establish a military system to cope with small unmanned aerial vehicles (UAVs)...
Celltrion’s Vegzelma listed on US PBM preferred drug list
South Korea's Celltrion Healthcare Co. announced on Tuesday that its anti-cancer biosimilar Vegzelma (active ingredient: bevacizumab) was listed as ...
HD Hyundai builds Aegis destroyer with anti-ballistic missiles
ULSAN, South Korea – At the shipyard of HD Hyundai Heavy Industries Co. on Nov. 20 in Ulsan, South Gyeongsang Province, South Korea's ne...
NKMax to perform first tests on dementia cell therapy in US
NKMax Co., South Korea's largest developer of natural killer (NK) cell therapies, will conduct its first clinical trials in the US for its candidate...
VaxCell-Bio applies for approval of anti-cancer drug for dogs
South Korea’s VaxCell Biotherapeutics Co. (VaxCell-Bio) on Tuesday announced its application for approval for Vaxleukin-15, an anti-cancer dru...
Hanmi Pharma’s Phase 3 trials for anti-obesity medicine approved
South Korea’s Hanmi Pharmaceutical Co. on Monday said the Ministry of Food and Drug Safety approved Phase 3 clinical trials for the company&...
Korea’s antitrust body grants conditional OK to Broadcom-VMware deal
South Korea’s antitrust regulator on Monday granted conditional approval for US smartphone components maker Broadcom Inc.’s proposed pur...
Humedix gets gov't OK for trials of dementia candidate drug
South Korea’s Humedix Co., a developer of biological and pharmaceutical products, on Tuesday said it received approval from the Ministry of Fo...
Five most common frustrations of Korean entrepreneurs
A South Korean company recently gave up on its plan to venture into the burgeoning robot market.Fair-trade regulations that prohibit the creation of...
Vuno's brain imaging AI medical device secures FDA certification
South Korea's medical device startup Vuno announced on Tuesday that its AI-powered brain quantification device Vuno Med-DeepBrain has received the 5...
Japanese steelmakers flood South Korea on back of weaker yen
Japanese steelmakers are expanding their market shares in South Korea, backed by the yen's drop against the Korean won to the lowest in eight years....
Genome & Co.’s bile duct cancer drug candidate enters Phase 2 trials
Genome & Company, a South Korean developer of microbiome-based drugs, on Tuesday said its GEN-001, a leading immunotherapy drug candidate for bi...
